Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …

Background Inflammation may play an important role in cancer progression, and a high
neutrophil-to-lymphocyte ratio (NLR) has been reported to be a poor prognostic indicator in …

Cellular-mediated inflammatory response, lymphocytes, neutrophils, and monocytes are
increasingly being recognised as having an important role in tumorigenesis and …

Background: Inflammation influences cancer development and progression. An elevated
platelet to lymphocyte ratio (PLR), a marker of inflammation, has been linked to poor …

Background: Peripheral blood-derived inflammation-based scores such as the neutrophil–
lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) have recently been proposed …

Background. Systemic inflammation in colorectal cancer (CRC) may be reflected by
neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and mean platelet …

Background The presence of a high neutrophil-to-lymphocyte ratio (NLR) has been
associated with increased mortality in several malignancies. Here, we quantify the effect of …

Aims This study aimed to evaluate the prognostic effect of neutrophil‐to‐lymphocyte ratio
(NLR) and platelet‐to‐lymphocyte ratio (PLR) for patients with breast cancer (BC). Methods …

Background Recently, more and more studies investigated the association of inflammation
parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various …

Background: The elevation of the platelet-to-lymphocyte ratio (PLR), an easily applicable
blood test based on platelet and lymphocyte counts has been associated with poor …